JPRN-UMIN000008046已完成未知
Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors. - Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors.
Seta Clinic Group0 个研究点目标入组 20 人开始时间: 2012年5月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: (1) Pulmonary fibrosis or interstitial pneumonia, or history or predisposition of them; (2) Serious drug allergy; (3) Positive for HIV or HTLV-1; (4) Active autoimmune disease; (5) Continuous systemic administration of steroids; (6) Other cancers; (7) Active infections; (8) Pregnant or lactating; (9) T cell, NK cell lymphoma and leukemia; (10) Serious cardiac disease; (11) Any reason why, in the opinion of the investigator, the patient should not participate.
研究者
相似试验
招募中
不适用
Clinical prospective study to investigate efficacy and safety of immune-cell therapy for malignant tumorsMalignant tumorJPRN-UMIN000004610Kanazawa university600
已完成
不适用
Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapyMalignant tumor (all HLA types)JPRN-UMIN000009447Seta Clinic Group5
已完成
不适用
The prospective study of the clinical efficacy/adverse event of regorafenib in unresectable metastatic and advanced colorectal cancerColorectal cancerJPRN-UMIN000015404Department of Clinical Oncology, Akita University Hospital50
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis - Tretinoin bei AKMedDRA version: 9.1Level: LLTClassification code 10000614Term: Actinic keratosisactinic keratosisEUCTR2007-000093-23-DEAlmirall Hermal GmbH
进行中（未招募）
不适用
Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC) - Verrumal in AKactinic keratosisEUCTR2006-005432-24-DEHermal Kurt Herrmann GmbH & Co OHG15